Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, said Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer
MeAgain turns that headline number into a weekly habit with a dose log, medication graph, meal tracking, and weight charts built for a long timeline
13 , 1759720X211015006 (2021)
These findings demonstrate that CB0313.1 prevents high fat diet-induced obesity, and this effect may be associated with increased glucose, proteins oxidation and decreased fat oxidation
Parents may observe a fast-growing pale spot on one side of the face, trunk, or limb